Bellini Roberto 4
4 · Inhibikase Therapeutics, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Bellini Roberto
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-14+73,580→ 73,580 totalExercise: $2.35Exp: 2035-02-14→ Common Stock (73,580 underlying) - Award
Stock Option (Right to Buy)
2025-02-14+116,585→ 116,585 totalExercise: $2.35Exp: 2035-02-14→ Common Stock (116,585 underlying)
Footnotes (2)
- [F1]The options vested and became exercisable on February 14, 2025.
- [F2]The options will vest and become exercisable in two equal annual installments on October 24, 2025 and October 24, 2026.